论文部分内容阅读
睾丸转移性生殖细胞癌的化疗,已取得满意的疗效;以顺氯胺铂(Cisplatine)为主治疗病人中70～80%,化疗后存活达五年。目前对化疗后长期并发症极为重视。本文总结睾丸肿瘤化疗后短期和长期的并发症。目前应用的标准化疗药物包括:长春花硷(Vinblastine)、争光霉素(bleomycin),顺氯胺铂(Cisplatine)或上述三种药物(VBP)与更生霉素(Dactinomycin)、放线菌素actinomycin-D,环磷酰胺(Cyclophosphamide VAB-6)联合应用。有的加用长春新硷(Vincrintine)、氨甲喋呤(Methotrexate)、鬼臼乙叉甙(Etoposide VB-16)。每一种药,可产
Chemotherapy of testicular metastatic germ cell carcinoma has achieved satisfactory results; 70 to 80% of patients are treated with cisplatin (Cisplatine) and survived after chemotherapy for five years. The current long-term complications after chemotherapy are extremely important. This article summarizes the short- and long-term complications of testicular tumor chemotherapy. Current standard chemotherapy drugs include: Vinblastine, bleomycin, Cisplatine or VBP and Dactinomycin, actinomycin -D, Cyclophosphamide VAB-6 combined application. Some use Vincintiny, Methotrexate, and Etoposide VB-16. Each medicine can be produced